Skip to content
BMYBristol-Myers Squibb Company

BMY Earnings

Bristol-Myers Squibb Company next reports earnings on October 29, 2026. Track record: 4/4 beats.

Next Earnings In

43Days
:
13Hours
:
10Min
:
28Sec

Thursday, October 29, 2026

Current Price

$63.73

EPS Estimate

Earnings Per Share

$1.73

+6.3% YoY

Trailing EPS

Last 12 months earnings

$4.54

Beat Rate

4/4

100%

Forward P/E

Price-to-Earnings ratio

9.7

Margin: 18.9%

Analyst Rating

Buy

24 analysts

Analyst Sentiment

Buy24 analysts
Target: $66.42+4.2%Full analysis →

Earnings History

4/4 Beats
QuarterEPS Est.EPS ActualSurpriseResult
2026-06-30$1.60$2.04+27.7%Beat
2026-03-31$1.42$1.58+11.2%Beat
2025-12-31$1.20$1.26+4.6%Beat
2025-09-30$1.52$1.63+7.6%Beat

Growth Estimates

PeriodEPS Est.Growth
Current Qtr(0q)$1.73+6.3%
Next Qtr(+1q)$1.59+26.5%
Current Year(0y)$6.95+13.0%
Next Year(+1y)$6.56-5.6%

Next Quarter Estimates

EPS Estimate

Earnings Per Share

$1.73

Revenue Estimate

$12.7B

Annual EPS Est.

$6.95

+13.0% YoY

BMY Earnings FAQ

When is BMY's next earnings date?

Bristol-Myers Squibb Company (BMY) is expected to report earnings on October 29, 2026. The consensus EPS estimate is $1.73.

Does BMY usually beat earnings estimates?

Bristol-Myers Squibb Company has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).

What is BMY's trailing EPS?

Bristol-Myers Squibb Company's trailing twelve-month EPS is $4.54. This is calculated from the last four quarters of reported earnings.

What do analysts think about BMY?

24 Wall Street analysts cover Bristol-Myers Squibb Company. The consensus rating is "Buy" with an average price target of $66.42, implying 4.2% upside from the current price.